Biofrontera Inc. (BFRI) Q2 2026 Earnings Call

Investor webinar replay

Replay transcript excerpt

Welcome to the Biofrontera Second Quarter twenty twenty six Financial Results and Business Update Conference Call. At this time, all participants are in listen only mode. After today's prepared remarks, there will be an opportunity to ask questions. Please note this event is being recorded. I would now like to turn the conference over to Good morning, and welcome to Biofrontera Inc. Second Quarter twenty twenty six Financial Results and Business Update Conference Call. Please note that certain information discussed during today's call by management is covered under the Safe Harbor provisions of the Private Securities Litigation Act. We caution listeners that Biofrontera's management will be making forward looking statements and that actual results may differ materially from those stated or implied by these forward looking statements due to risks and uncertainties associated with the company's business. Forward looking statements on today's call include statements regarding the company's full year 2026 revenue goals, the anticipated effects of the International Trade Commission orders and the company's remediation plan, the company's liquidity and the ability to continue as a going concern, the outcome of pending patent proceedings and the potential approval and launch of new indications for Ameluz. All risks and uncertainties are detailed and are qualified by the cautionary statements contained in Biofrontera's press release and SEC filings, including the company's quarterly reports on Form 10 Q for the quarter ended 06/30/2026, and the company's annual report on Form 10 ks for the year ended 12/31/2025. Also, this conference call contains time sensitive information that is accurate only as of the date of this live broadcast. Biofrontera undertakes no obligation to r...